BERLIN (Reuters) – Swiss drugs regulator Swissmedic said on Monday that it has approved the first bivalent Covid-19 booster vaccine in the country.
Moderna’s Spikevax vaccine, which contains mRNA against two coronavirus variants, is authorized for anyone 18 years or older, said Swissmedic.
(Writing by Miranda Murray; Editing by Maria Sheahan)
